(MedPage Today) — CHICAGO — When treating patients with systemic lupus erythematosus (SLE) with hydroxychloroquine (HCQ), following standard dosing recommendations risks excessive toxicity or suboptimal efficacy, a researcher warned here….
Source link : https://www.medpagetoday.com/meetingcoverage/acr/118202
Author :
Publish date : 2025-10-29 14:51:00
Copyright for syndicated content belongs to the linked Source.
